IL49100A - Gamma-crystalline anhydrate form of sodium 7-(d-alpha-formyloxy-alpha-phenyl-acet-amido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate - Google Patents

Gamma-crystalline anhydrate form of sodium 7-(d-alpha-formyloxy-alpha-phenyl-acet-amido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate

Info

Publication number
IL49100A
IL49100A IL49100A IL4910076A IL49100A IL 49100 A IL49100 A IL 49100A IL 49100 A IL49100 A IL 49100A IL 4910076 A IL4910076 A IL 4910076A IL 49100 A IL49100 A IL 49100A
Authority
IL
Israel
Prior art keywords
alpha
ylthiomethyl
acet
cephem
formyloxy
Prior art date
Application number
IL49100A
Other languages
English (en)
Other versions
IL49100A0 (en
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL49100A0 publication Critical patent/IL49100A0/xx
Publication of IL49100A publication Critical patent/IL49100A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL49100A 1975-04-11 1976-02-25 Gamma-crystalline anhydrate form of sodium 7-(d-alpha-formyloxy-alpha-phenyl-acet-amido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate IL49100A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/567,324 US4006138A (en) 1975-04-11 1975-04-11 Crystalline form of sodium O-formylcefamandole

Publications (2)

Publication Number Publication Date
IL49100A0 IL49100A0 (en) 1976-04-30
IL49100A true IL49100A (en) 1979-03-12

Family

ID=24266692

Family Applications (1)

Application Number Title Priority Date Filing Date
IL49100A IL49100A (en) 1975-04-11 1976-02-25 Gamma-crystalline anhydrate form of sodium 7-(d-alpha-formyloxy-alpha-phenyl-acet-amido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate

Country Status (31)

Country Link
US (1) US4006138A (de)
JP (1) JPS51123812A (de)
AR (1) AR210880A1 (de)
AT (1) AT343806B (de)
AU (1) AU500013B2 (de)
BE (1) BE840179A (de)
CA (1) CA1045114A (de)
CH (1) CH621554A5 (de)
CS (1) CS191970B2 (de)
DD (1) DD125950A5 (de)
DE (1) DE2614669C2 (de)
DK (1) DK148022C (de)
ES (1) ES446907A1 (de)
FI (1) FI65069C (de)
FR (1) FR2306698A1 (de)
GB (1) GB1546898A (de)
GR (1) GR59912B (de)
HU (1) HU175592B (de)
IL (1) IL49100A (de)
LU (1) LU74740A1 (de)
MX (1) MX3687E (de)
NL (1) NL184258C (de)
NO (1) NO151748C (de)
OA (1) OA05290A (de)
PL (1) PL104803B1 (de)
PT (1) PT64917B (de)
RO (1) RO68501A (de)
SE (1) SE435290B (de)
SU (1) SU668608A3 (de)
YU (1) YU40643B (de)
ZA (1) ZA761103B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE7503274L (sv) * 1974-04-11 1975-10-13 Ciba Geigy Ag Cefalosporin
US4085277A (en) * 1975-01-30 1978-04-18 Fujisawa Pharmaceutical Co., Ltd. 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid
FR2400519A1 (fr) * 1977-08-17 1979-03-16 Roussel Uclaf Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4946838A (en) * 1981-07-13 1990-08-07 E. R. Squibb & Sons, Inc. Crystalline anhydrous aztreonam
EP0432297A1 (de) * 1989-12-13 1991-06-19 Technologitschen Kombinat Sa Promischlena Mikrobiologia Verfahren zur Herstellung des Natriumsalzes von O-formylcefamandol
US5492903A (en) * 1990-06-19 1996-02-20 Takeda Chemical Industries Ltd. Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he
US7842791B2 (en) * 2002-12-19 2010-11-30 Nancy Jean Britten Dispersible pharmaceutical compositions
WO2013057196A1 (en) * 2011-10-20 2013-04-25 Dsm Sinochem Pharmaceuticals Netherlands B.V. Process for the preparation of cefamandole nafate
CN104530086B (zh) * 2014-12-16 2015-12-09 天津大学 头孢孟多酯钠化合物的新晶型及其结晶制备方法
CN105037392A (zh) * 2015-08-13 2015-11-11 青岛蓝盛洋医药生物科技有限责任公司 一种杀菌药物头孢孟多酯钠化合物及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3887551A (en) * 1964-11-04 1975-06-03 Glaxo Lab Ltd Crystalline forms of cephaloridine
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds

Also Published As

Publication number Publication date
PT64917B (en) 1977-08-24
PL104803B1 (pl) 1979-09-29
ZA761103B (en) 1977-10-26
CA1045114A (en) 1978-12-26
FR2306698B1 (de) 1979-10-05
NO151748C (no) 1985-06-05
CS191970B2 (en) 1979-07-31
JPS6110474B2 (de) 1986-03-29
SU668608A3 (ru) 1979-06-15
AR210880A1 (es) 1977-09-30
DE2614669C2 (de) 1984-09-27
JPS51123812A (en) 1976-10-28
AU1143576A (en) 1977-09-01
NO761017L (de) 1976-10-12
NL184258B (nl) 1989-01-02
YU79276A (en) 1982-10-31
YU40643B (en) 1986-04-30
FI65069B (fi) 1983-11-30
AT343806B (de) 1978-06-26
SE7602565L (sv) 1976-10-12
HU175592B (hu) 1980-09-28
IL49100A0 (en) 1976-04-30
DK148022B (da) 1985-02-04
GR59912B (en) 1978-03-20
ATA258476A (de) 1977-10-15
FI65069C (fi) 1984-03-12
PT64917A (en) 1976-04-01
FI760788A (de) 1976-10-12
DD125950A5 (de) 1977-06-01
NL7603660A (nl) 1976-10-13
FR2306698A1 (fr) 1976-11-05
DK148022C (da) 1985-07-22
BE840179A (fr) 1976-09-30
OA05290A (fr) 1981-02-28
US4006138A (en) 1977-02-01
GB1546898A (en) 1979-05-31
CH621554A5 (de) 1981-02-13
SE435290B (sv) 1984-09-17
DK150676A (da) 1976-10-12
AU500013B2 (en) 1979-05-10
MX3687E (es) 1981-04-29
DE2614669A1 (de) 1976-10-21
NL184258C (nl) 1989-06-01
ES446907A1 (es) 1977-09-16
RO68501A (ro) 1981-04-30
NO151748B (no) 1985-02-18
LU74740A1 (de) 1976-11-11

Similar Documents

Publication Publication Date Title
IL50476A (en) N-thilocarbonyl derivatives of n-phosphonomethylglycine
JPS51123813A (en) Production of cephalosporin for nonnaural administration
IL49100A (en) Gamma-crystalline anhydrate form of sodium 7-(d-alpha-formyloxy-alpha-phenyl-acet-amido)-3-(1-methyl-1h-tetrazol-5-ylthiomethyl)-3-cephem-4-carboxylate
JPS5214793A (en) Production of cephalosporin compound
JPS5251389A (en) Production of cephalosporin intermediate
GB1542904A (en) 3-triazolylthio derivatives of ureido-7alpha-methoxy or desmethoxy cephalosporins
NZ182694A (en) The crystalline anhydrate monohydrate methanol solvate forms of sodium 7-(d-2-hydroxy-2-phenylacetamido)-3-(1-methyl-1h-tetrazol-s-ylthiomethyl)-3-cephem-4-carboxylate and pharmaceutical compositions
JPS5285188A (en) Substituted nnmethylene derivative of thienacmycine
GB2043070B (en) Preparation of sodium cefuroxime
IE42633L (en) Purification of cephamycin c
GB1522238A (en) Trifluoromethylthio derivatives of cyproheptadine
GB2040942B (en) Derivatives of cephalosporin c
NZ179914A (en) 7-(substituted phenyl-acetamido)cephalosporins and pharmaceutical compositions
GR61821B (en) Preparation process of cephalosporins
JPS51122094A (en) Production of heterocyclic compound
JPS55136289A (en) Manufacture of cephalosporin compound
JPS5289668A (en) Production of heterocyclic compound
JPS5271499A (en) Improvement of solubility of steviocide
JPS5253890A (en) Production of cephalosporin type compound
GR61667B (en) Preparation process of novel cephalosporins
GB1515809A (en) Preparation of cephamycin c
JPS5278183A (en) Center of lathe
JPS5559194A (en) Manufacture of cephalosporin compound
EG12152A (en) Process for the preparation of 7-(d-2-amino-3-phenylacetamido)-3-methyl-3-cephem-4-carboxylic acid
JPS5236687A (en) Production of cephalosporin derivative